ERBB2 activating mutations, on the other hand, are often detected in breast carcinomas lacking ERBB2 amplification and may be found also in other histological subtypes, such as lobular carcinoma [1, 8, 9]. Here, ERBB2 is linked to breast lobular carcinoma.